2021 annual financial data
Avalo Therapeutics 2021 Operating income growth
Direct answer
Operating income growth was -204.73%.
Operating income was -82,134,000 USD and net income was -84,376,000 USD.
Operating cash flow was -70,892,000 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,398,000 USD
- Operating income
- -82,134,000 USD
- Net income
- -84,376,000 USD
- Operating cash flow
- -70,892,000 USD